Robert Mueller

Robert Mueller

Senior Group Leader, Late-Stage Pharmaceutical and Process Development
Roche

Since 2010, Dr. Müller leads a technical development group in the Late-Stage Pharmaceutical and Processing Development at F. Hoffmann-La Roche Ltd (Basel, Switzerland) with the main focus based on commercial protein formulation and process development.

2008, Dr. Müller took over a formulation research lab in the group of Formulation R&D Biologics at F. Hoffmann-La Roche Ltd (Basel, Switzerland) working on early-stage biotech R&D projects.

From 2005-2008, he was working as formulation scientist in the group of Formulation R&D Biologics at F. Hoffmann-La Roche Ltd (Basel, Switzerland), with the main focus based on high concentration protein formulation development.

From 2001-2005, he was working as process and formulation scientist at Merck KGaA (Darmstadt, Germany) in the group of Formulation Development Sterile Dosage Forms. He has technical experience in formulation development of sterile dosage forms including biologics, combination products and application of quality by design principles, production of clinical trial and non-clinical study material, up-scaling and process validation.

Dr. Müller holds a PhD in pharmaceutical technology from the Martin-Luther University Halle/Saale, Germany and an engineering degree in Biotechnology obtained at the University of Applied Sciences Bingen/ Rhein, Germany.